Cargando…
Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance
Although all wild-type bacterial populations exhibit antibiotic tolerance, bacterial mutants with higher or lower tolerant subpopulation sizes have been described. We recently showed that in mycobacteria, phenotypically-resistant subpopulations can grow in bulk-lethal concentrations of rifampicin, a...
Autores principales: | Wang, Bi-Wei, Zhu, Jun-Hao, Javid, Babak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242378/ https://www.ncbi.nlm.nih.gov/pubmed/32439911 http://dx.doi.org/10.1038/s41598-020-65308-2 |
Ejemplares similares
-
Kasugamycin potentiates rifampicin and limits emergence of resistance in Mycobacterium tuberculosis by specifically decreasing mycobacterial mistranslation
por: Chaudhuri, Swarnava, et al.
Publicado: (2018) -
Navigating a Path to Rifampicin Resistance in Tuberculosis
por: Agarwal, Sakshi, et al.
Publicado: (2023) -
The conserved GTPase LepA contributes mainly to translation initiation in Escherichia coli
por: Balakrishnan, Rohan, et al.
Publicado: (2014) -
Clinically Relevant Mutations of Mycobacterial GatCAB Inform Regulation of Translational Fidelity
por: Li, Yang-Yang, et al.
Publicado: (2021) -
Quel vide pour l'EPA?
por: Poncet, A
Publicado: (1983)